Article

(2022) CRISPR: A Promising Tool for Cancer Therapy. Current molecular medicine. ISSN 1875-5666 (Electronic) 1566-5240 (Linking)

(2022) MicroRNAs and Efferocytosis: Implications for Diagnosis and Therapy. Mini-Reviews in Medicinal Chemistry. pp. 2641-2660. ISSN 1389-5575

(2022) A comprehensive review of IL-26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections. Immunology. pp. 44-60. ISSN 0019-2805

(2022) The role of efferocytosis in neuro-degenerative diseases. Neurological Sciences. p. 11. ISSN 1590-1874

(2021) Chemokine CXCL14; a double-edged sword in cancer development. International Immunopharmacology. p. 9. ISSN 1567-5769

(2021) Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy. IUBMB life. pp. 659-669. ISSN 1521-6543

(UNSPECIFIED) Effect of diabetes on efferocytosis process. Molecular Biology Reports. p. 15. ISSN 0301-4851